2 false false false false false false false false false false true false false false false false false No description of principal activity 2023-12-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11679289 2023-12-01 2024-11-30 11679289 2024-11-30 11679289 2023-11-30 11679289 2022-12-01 2023-11-30 11679289 2023-11-30 11679289 2022-11-30 11679289 bus:Director1 2023-12-01 2024-11-30 11679289 core:WithinOneYear 2024-11-30 11679289 core:WithinOneYear 2023-11-30 11679289 bus:Micro-entities 2023-12-01 2024-11-30 11679289 bus:AuditExemptWithAccountantsReport 2023-12-01 2024-11-30 11679289 bus:SmallCompaniesRegimeForAccounts 2023-12-01 2024-11-30 11679289 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 11679289 bus:FullAccounts 2023-12-01 2024-11-30
COMPANY REGISTRATION NUMBER: 11679289
Calyx Neurological Services (CNS) Limited
Unaudited financial statements
30 November 2024
Calyx Neurological Services (CNS) Limited
Statement of financial position
30 November 2024
2024
2023
£
£
£
£
Fixed assets
18,690
22,068
-------
-------
Current assets
552,512
390,113
Prepayments and accrued income
190
424
---------
---------
552,702
390,537
Creditors: amounts falling due within one year
( 75,427)
( 47,139)
---------
---------
Net current assets
477,275
343,398
---------
---------
Total assets less current liabilities
495,965
365,466
Accruals and deferred income
( 2,445)
( 2,955)
---------
---------
493,520
362,511
---------
---------
Capital and reserves
493,520
362,511
---------
---------
Notes to the financial statements
1. Employee numbers
The average number of employees during the year was 2 (2023: 2 ).
2. Directors' advances, credits and guarantees
At the year end, the directors owed the Company £579 (2023: £435). No interest is due on the outstanding amount.
For the year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 4 June 2025 , and are signed on behalf of the board by:
Dr M Lee
Director
Company registration number: 11679289
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Bankside 300, Peachman Way, Broadland Business Park, Norwich, Norfolk, NR7 0LB, United Kingdom.